Back
UroGen Pharma Stock Price Chart
Sponsored
URGN
Sponsored
The truth about AI stocks (must see)
Learn the names of all 10 stocks here. FREE.
Buy
51
URGN
UroGen Pharma
Last Price:
12.47
Seasonality Move:
5.53%
7 Day Trial
ALL ACCESS PASS
$
7
Don't put a penny in AI stocks until you read this
Discover this under-the-radar AI stock now, ahead of the crowd.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
UroGen Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.42 | Buy |
20-day SMA: | 12.56 | Sell |
50-day SMA: | 13.41 | Sell |
200-day SMA: | 14.93 | Sell |
8-day EMA: | 12.49 | Sell |
20-day EMA: | 12.65 | Sell |
50-day EMA: | 13.34 | Sell |
200-day EMA: | 14.25 | Sell |
UroGen Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 45.42 | Sell |
Chaikin Money Flow: | 215195 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.27 - 13.13) | Sell |
Bollinger Bands (100): | (12.84 - 16.3) | Sell |
UroGen Pharma Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for UroGen Pharma Stock
Is UroGen Pharma Stock a Buy?
- UroGen Pharma share price is 12.47 while URGN 8-day simple moving average is 12.42, which is a Buy signal.
- The stock price of URGN is 12.47 while UroGen Pharma 20-day SMA is 12.56, which makes it a Sell.
- UroGen Pharma 50-day simple moving average is 13.41 while URGN share price is 12.47, making it a Sell technically.
- URGN stock price is 12.47 and UroGen Pharma 200-day simple moving average is 14.93, creating a Sell signal.
URGN Technical Analysis vs Fundamental Analysis
Buy
51
UroGen Pharma (URGN)
is a Buy
Is UroGen Pharma a Buy or a Sell?
-
UroGen Pharma stock is rated a Buy
The current UroGen Pharma [URGN] share price is $12.47. The Score for URGN is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
UroGen Pharma Stock Info
Market Cap:
525.16M
Price in USD:
12.47
Share Volume:
368.91K
UroGen Pharma 52-Week Range
52-Week High:
20.70
52-Week Low:
10.60
Buy
51
UroGen Pharma (URGN)
is a Buy
UroGen Pharma Share Price Forecast
-
What is the UroGen Pharma stock price today?
The UroGen Pharma stock price is 12.47 USD today. -
Will URGN stock go up or go down?
UroGen Pharma> share price is forecast to RISE/FALL based on technical indicators -
Is UroGen Pharma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, UroGen Pharma is not overvalued.
Is UroGen Pharma Stock a Buy?
- UroGen Pharma share price is 12.47 while URGN 8-day exponential moving average is 12.49, which is a Sell signal.
- The stock price of URGN is 12.47 while UroGen Pharma 20-day EMA is 12.65, which makes it a Sell.
- UroGen Pharma 50-day exponential moving average is 13.34 while URGN share price is 12.47, making it a Sell technically.
- URGN stock price is 12.47 and UroGen Pharma 200-day simple moving average is 14.25, creating a Sell signal.
Fundamental Analysis of UroGen Pharma
Is UroGen Pharma a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.62 per share.
Technical Analysis of UroGen Pharma
Should I short UroGen Pharma stock?
- URGN Moving Average Covergence Divergence (MACD) indicator is -0.27, suggesting UroGen Pharma is a Sell
- UroGen Pharma Relative Strength Index (RSI) is 45.42, which suggest UroGen Pharma is oversold
- The Bollinger Bands (25) for UroGen Pharma is (12.27 - 13.13), which suggest UroGen Pharma is a Sell
- The Bollinger Bands (100) for UroGen Pharma is (12.84 - 16.3), which suggest UroGen Pharma is a Sell
* UroGen Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.